ARCHIVES

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

This article is from The Cancer Letter archive.

Vol. 35 No. 15 | April 17, 2009

Download PDF Visit The Full Archive

Related Articles

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

August 31, 2001

Study: Partial Kidney Removal Leads to Greater Survival

March 29, 2013

1.7% Cut Expected in NCI Budget Under Deficit Agreement

November 24, 1989

NCAB Settles New Touchy PDQ Issues

June 7, 1985

$293 Million NCI Budget Cut To Drop Grant Success Rate

May 10, 2013

Vanderbilt-Ingram Wins NCI SPORE Grant

April 19, 2002